文献
J-GLOBAL ID:201902235194371854
整理番号:19A2469875
LC-MS/MS,ELISAおよびマイクロ流体ベース免疫学的試験の間のバイオ分析技術を用いた非小細胞肺癌患者の血漿中のベバシズマブ定量化結果の比較【JST・京大機械翻訳】
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay
著者 (9件):
Iwamoto Noriko
(Leading Technology of Bioanalysis and Protein Chemistry, Shimadzu Corporation, Kyoto, Japan)
,
Iwamoto Noriko
(Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA)
,
Takanashi Megumi
(Leading Technology of Bioanalysis and Protein Chemistry, Shimadzu Corporation, Kyoto, Japan)
,
Shimada Takashi
(Leading Technology of Bioanalysis and Protein Chemistry, Shimadzu Corporation, Kyoto, Japan)
,
Shimada Takashi
(Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA)
,
Sasaki Jiichiro
(Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan)
,
Hamada Akinobu
(Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan)
,
Hamada Akinobu
(Department of Pharmacology and Therapeutics, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Tokyo, Japan)
,
Hamada Akinobu
(Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Tokyo, Japan)
資料名:
AAPS Journal
(AAPS Journal)
巻:
21
号:
6
ページ:
1-8
発行年:
2019年
JST資料番号:
W3977A
ISSN:
1550-7416
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)